rs150267054
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000601.6(HGF):c.137C>T(p.Ala46Val) variant causes a missense change. The variant allele was found at a frequency of 0.00177 in 1,596,858 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 4 hom. )
Consequence
HGF
NM_000601.6 missense
NM_000601.6 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 4.49
Genes affected
HGF (HGNC:4893): (hepatocyte growth factor) This gene encodes a protein that binds to the hepatocyte growth factor receptor to regulate cell growth, cell motility and morphogenesis in numerous cell and tissue types. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate alpha and beta chains, which form the mature heterodimer. This protein is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. This protein also plays a role in angiogenesis, tumorogenesis, and tissue regeneration. Although the encoded protein is a member of the peptidase S1 family of serine proteases, it lacks peptidase activity. Mutations in this gene are associated with nonsyndromic hearing loss. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009344757).
BP6
Variant 7-81762824-G-A is Benign according to our data. Variant chr7-81762824-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 360784.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=1}. Variant chr7-81762824-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HGF | NM_000601.6 | c.137C>T | p.Ala46Val | missense_variant | 2/18 | ENST00000222390.11 | NP_000592.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGF | ENST00000222390.11 | c.137C>T | p.Ala46Val | missense_variant | 2/18 | 1 | NM_000601.6 | ENSP00000222390 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00133 AC: 202AN: 151986Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
202
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00178 AC: 446AN: 250740Hom.: 0 AF XY: 0.00179 AC XY: 242AN XY: 135536
GnomAD3 exomes
AF:
AC:
446
AN:
250740
Hom.:
AF XY:
AC XY:
242
AN XY:
135536
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00182 AC: 2632AN: 1444754Hom.: 4 Cov.: 27 AF XY: 0.00176 AC XY: 1269AN XY: 719900
GnomAD4 exome
AF:
AC:
2632
AN:
1444754
Hom.:
Cov.:
27
AF XY:
AC XY:
1269
AN XY:
719900
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00133 AC: 202AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.00136 AC XY: 101AN XY: 74354
GnomAD4 genome
AF:
AC:
202
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
101
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
13
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
19
ExAC
AF:
AC:
218
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 06, 2018 | This variant is associated with the following publications: (PMID: 29924831) - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The HGF p.Ala46Val variant was not identified in the literature nor was it identified in Cosmic. The variant was identified in dbSNP (ID: rs150267054), ClinVar (classified as a VUS by Illumina for Nonsyndromic Hearing Loss, Mixed and as likely benign by Laboratory for Molecular Medicine) and LOVD 3.0 (classified as a VUS and likely benign). The variant was also identified in control databases in 482 of 282092 chromosomes at a frequency of 0.001709 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 53 of 10362 chromosomes (freq: 0.005115), European (Finnish) in 66 of 25094 chromosomes (freq: 0.00263), European (non-Finnish) in 320 of 128720 chromosomes (freq: 0.002486), Other in 5 of 7206 chromosomes (freq: 0.000694), Latino in 22 of 35338 chromosomes (freq: 0.000623), South Asian in 10 of 30548 chromosomes (freq: 0.000327) and African in 6 of 24922 chromosomes (freq: 0.000241) but was not observed in the East Asian population. The p.Ala46 residue is conserved in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Nonsyndromic Hearing Loss, Mixed Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 30, 2016 | p.Ala46Val in exon 2 of HGF: This variant is not expected to have clinical signi ficance because it has been identified in 0.3% (196/64768) of European chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs150267054). - |
HGF-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 11, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.;.;.;.;.;D;D;.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;L;L;L;.;.;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
.;N;N;N;N;N;.;N;.;N;N
REVEL
Benign
Sift
Benign
.;T;T;T;T;T;.;T;.;T;D
Sift4G
Benign
.;T;T;T;T;T;.;D;.;.;.
Polyphen
D;D;P;P;P;.;.;.;.;.;.
Vest4
0.31, 0.33, 0.35, 0.35, 0.32, 0.32
MVP
0.64
MPC
1.1
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at